Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AdaptHealth (AHCO) Depreciation and Depletion (2019 - 2025)

AdaptHealth (AHCO) has 7 years of Depreciation and Depletion data on record, last reported at $92.6 million in Q4 2025.

  • For Q4 2025, Depreciation and Depletion rose 8.94% year-over-year to $92.6 million; the TTM value through Dec 2025 reached $361.6 million, up 5.39%, while the annual FY2025 figure was $361.6 million, 5.39% up from the prior year.
  • Depreciation and Depletion reached $92.6 million in Q4 2025 per AHCO's latest filing, roughly flat from $92.6 million in the prior quarter.
  • Across five years, Depreciation and Depletion topped out at $92.6 million in Q3 2025 and bottomed at $36.9 million in Q1 2021.
  • Average Depreciation and Depletion over 5 years is $78.9 million, with a median of $85.4 million recorded in 2024.
  • Peak YoY movement for Depreciation and Depletion: surged 206.51% in 2021, then decreased 5.96% in 2023.
  • A 5-year view of Depreciation and Depletion shows it stood at $65.0 million in 2021, then surged by 41.95% to $92.3 million in 2022, then decreased by 5.96% to $86.8 million in 2023, then dropped by 2.07% to $85.0 million in 2024, then rose by 8.94% to $92.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Depreciation and Depletion were $92.6 million in Q4 2025, $92.6 million in Q3 2025, and $87.2 million in Q2 2025.